Research Model
Early Development Trials

> Proof-of-Concept (POC)

> Adaptive Design Studies: HNV and Patient

> First-in-Human (FIH)

> Single Ascending Dose (SAD)

> Multiple Ascending Dose (MAD)

> Bioavailability/Bioequivalence (BA/BE)

> Pharmacokinetics/Pharmacodynamics (PK/PD)

> Dose-Ranging and Tolerability

> Food Effect

> QT/QTc

> Drug-Drug Interaction

Headquarters: 10103 Metcalf Ave. | Overland Park, KS 66212 | Office: 913.696.1601 | Fax: 913.696.1640
Privacy Statement | Site Map | ©2011 All Rights Reserved, Vince and Associates Clinical Research